Please provide your email address to receive an email when new articles are posted on . In patients who underwent surgical bioprosthetic valve implantation or repair, early postoperative ...
GERRARDS CROSS, England, NICE Final Appraisal Determination recommends that edoxaban is a cost effective use of NHS resources. The National Institute for Health and Care Excellence (NICE) has ...
CHICAGO, IL—Following bioprosthetic valve surgery, anticoagulation with edoxaban (Savaysa; Daiichi Sankyo) is as effective as warfarin, although this strategy might come at a higher cost of bleeding, ...
Treatment with the direct factor Xa inhibitor edoxaban (Lixiana) resulted in low rates of clinically relevant bleeding and thromboembolism (TE) compared with standard-of-care (SOC) anticoagulants in ...
Please provide your email address to receive an email when new articles are posted on . CHICAGO — For children with rare heart conditions that increase risk for thromboembolism, daily edoxaban may be ...
Elderly patients with atrial fibrillation (AF) who are at high risk of bleeding may benefit from a low 15-mg dose of edoxaban, regardless of their frailty status, a subanalysis of the ELDERCARE-AF ...
Edoxaban, an oral anticoagulant, was equally or more effective than warfarin in reducing the risk of stroke and blood clots for patients after heart valve replacement surgery, according to preliminary ...
Deep vein thrombosis, pulmonary embolism (treatment, secondary prevention) - edoxaban tosylate [ID662]: final matrix Deep vein thrombosis, pulmonary embolism (treatment, secondary prevention) - ...
A direct oral anticoagulant (DOAC) passed a test of efficacy but tripped up over bleeding rates when used for patients who came out of successful transcatheter aortic valve replacement (TAVR) and ...
The National Institute for Health and Care Excellence (NICE) has recommended a new treatment to help patients suffering from blood clots in the legs and lungs. NICE has issued a Final Appraisal ...
A new study compares edoxaban anticoagulant with the standard of care in large randomized clinical trial. The anticoagulant edoxaban may be just as effective as warfarin for preventing heart attack or ...
Deep vein thrombosis, pulmonary embolism (treatment, secondary prevention) - edoxaban tosylate [ID662]: final matrix Deep vein thrombosis, pulmonary embolism (treatment, secondary prevention) - ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results